Over the last 50 years, therapeutic advances have increased survival from childhood and adolescent cancer. Nowadays, 80% of patients are disease-free five years after diagnosis. Yet, decades after diagnosis, late effects related to prior therapy can appear.
The FCCSS (French childhood cancer survivor study) is aimed at analysing those long-term effects, in order to prevent them. Moreover, the FCCSS study aims at investigating the economic, the social and the psychosocial outcomes of children and adolescents who have had cancer. Read more…
This web site was conceived to present the methodology and the scientific results of the FCCSS. It is first intended for study participants and for anyone interested in the issue of childhood cancer survivorship.